PMC:7105881 / 31922-32187 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1040","span":{"begin":98,"end":106},"obj":"Species"},{"id":"1041","span":{"begin":146,"end":154},"obj":"Species"},{"id":"1042","span":{"begin":155,"end":160},"obj":"Species"}],"attributes":[{"id":"A1040","pred":"tao:has_database_id","subj":"1040","obj":"Tax:694009"},{"id":"A1041","pred":"tao:has_database_id","subj":"1041","obj":"Tax:694009"},{"id":"A1042","pred":"tao:has_database_id","subj":"1042","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"protein developed high-titer S-specific antibodies with neutralizing activity against pseudotyped SARS-CoV expressing S protein of representative SARS-CoV human and palm civet strains (Tor2, GD03, and SZ3) isolated during the 2002 and 2003 or 2003 and 2004 outbreak"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T172","span":{"begin":0,"end":7},"obj":"Body_part"},{"id":"T173","span":{"begin":120,"end":127},"obj":"Body_part"},{"id":"T174","span":{"begin":165,"end":169},"obj":"Body_part"}],"attributes":[{"id":"A172","pred":"fma_id","subj":"T172","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A173","pred":"fma_id","subj":"T173","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A174","pred":"fma_id","subj":"T174","obj":"http://purl.org/sig/ont/fma/fma24920"}],"text":"protein developed high-titer S-specific antibodies with neutralizing activity against pseudotyped SARS-CoV expressing S protein of representative SARS-CoV human and palm civet strains (Tor2, GD03, and SZ3) isolated during the 2002 and 2003 or 2003 and 2004 outbreak"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T164","span":{"begin":98,"end":106},"obj":"Disease"},{"id":"T165","span":{"begin":146,"end":154},"obj":"Disease"}],"attributes":[{"id":"A164","pred":"mondo_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A165","pred":"mondo_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"protein developed high-titer S-specific antibodies with neutralizing activity against pseudotyped SARS-CoV expressing S protein of representative SARS-CoV human and palm civet strains (Tor2, GD03, and SZ3) isolated during the 2002 and 2003 or 2003 and 2004 outbreak"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T421","span":{"begin":69,"end":77},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T422","span":{"begin":155,"end":160},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"protein developed high-titer S-specific antibodies with neutralizing activity against pseudotyped SARS-CoV expressing S protein of representative SARS-CoV human and palm civet strains (Tor2, GD03, and SZ3) isolated during the 2002 and 2003 or 2003 and 2004 outbreak"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T188","span":{"begin":0,"end":7},"obj":"Chemical"},{"id":"T189","span":{"begin":120,"end":127},"obj":"Chemical"}],"attributes":[{"id":"A188","pred":"chebi_id","subj":"T188","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A189","pred":"chebi_id","subj":"T189","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"protein developed high-titer S-specific antibodies with neutralizing activity against pseudotyped SARS-CoV expressing S protein of representative SARS-CoV human and palm civet strains (Tor2, GD03, and SZ3) isolated during the 2002 and 2003 or 2003 and 2004 outbreak"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T524","span":{"begin":40,"end":50},"obj":"GO:0042571"},{"id":"T525","span":{"begin":98,"end":106},"obj":"SP_10"},{"id":"T526","span":{"begin":107,"end":117},"obj":"GO:0010467"},{"id":"T527","span":{"begin":118,"end":127},"obj":"PG_1"},{"id":"T528","span":{"begin":146,"end":154},"obj":"SP_10"},{"id":"T529","span":{"begin":155,"end":160},"obj":"SP_6;NCBITaxon:9606"},{"id":"T530","span":{"begin":165,"end":175},"obj":"SP_5"},{"id":"T30442","span":{"begin":40,"end":50},"obj":"GO:0042571"},{"id":"T88681","span":{"begin":98,"end":106},"obj":"SP_10"},{"id":"T39868","span":{"begin":107,"end":117},"obj":"GO:0010467"},{"id":"T37152","span":{"begin":118,"end":127},"obj":"PG_1"},{"id":"T62328","span":{"begin":146,"end":154},"obj":"SP_10"},{"id":"T47566","span":{"begin":155,"end":160},"obj":"SP_6;NCBITaxon:9606"},{"id":"T32795","span":{"begin":165,"end":175},"obj":"SP_5"}],"text":"protein developed high-titer S-specific antibodies with neutralizing activity against pseudotyped SARS-CoV expressing S protein of representative SARS-CoV human and palm civet strains (Tor2, GD03, and SZ3) isolated during the 2002 and 2003 or 2003 and 2004 outbreak"}